Perform Competitor Research In 30 Seconds – GreyB’ CompInsight
Have you considered that by solely performing competitor research based on their online presence and ranking, you miss many innovative companies working on similar technologies? These companies may have even patented their innovations, which makes them the REAL COMPETITORS to your business. After all, patent data reveals innovators entering your domain at an early stage- […]
Does the FDA’s warning mark an end to Ozempic?
The recent FDA controversy around Novo Nordisk’s Ozempic has brought many eyes to the drug. For the uninitiated, Ozempic (semaglutide) is an anti-obesity medication for long-term weight management. However, an FDA-approved label was recently updated to warn of potential serious intestinal side effects like obstruction or blockage. In this study, we see how this FDA […]
Lead the generic drug market with this one effective strategy
Closely monitoring the patent expirations of well-known branded drugs, such as Abilify for schizophrenia and Abaraxane for cancer treatment, is essential. This practice of monitoring patents can give generic drug makers a significant competitive edge, ultimately granting them an advantage in the generic drug market. As top blockbuster drugs approach patent expiration, strategic ANDA filings […]
15 Critical Factors Before Purchasing a Patent Portfolio
If patents are your bread and butter, you know as much as I do that a thorough patent portfolio analysis is critical before deciding to buy them. However, the situation gets complicated by thousands of patents in the portfolio. It begs the question: Should I hire specialists to conduct a thorough examination? Is it worth […]
Tap Into The Loteprednol Etabonate Generic Drug’s Transformational Potential
In 2020, the FDA approved loteprednol etabonate ophthalmic suspension 0.25% (Eysuvis, Kala Pharmaceuticals Inc.) for treating dry eye disease. As one of the most common ocular surface disorders, dry eye disease impacts 16.7 million to 50.2 million people in the U.S.A. Additionally, this disease costs over $55.4 billion to the economy each year. Eysuvis ophthalmic […]
Analyzing IP for Mergers & Acquisitions: A 3 Stage Framework
Mergers and acquisitions have been a core business strategy for companies across almost all industries. A key reason for M&A deals today is the need to harness cutting-edge technologies through targeted partnerships. This has led to a surge in M&As, focusing on companies that hold the coveted keys to groundbreaking innovations. As a result, analyzing […]
Why is drug exclusivity knowledge crucial for generic drug launches?
Monitoring the drug exclusivity expiration timelines is just as important as patent expiration date when identifying opportunities and timing generic launches. Having access to detailed exclusivity data can reveal openings for generic entry even when patents are still active. As top blockbuster drugs approach patent expiration, strategic ANDA filings are critical to secure early mover […]
Top 20 Patent Buyers Of Cancer Curing Technologies
During the second quarter of 2023, there was a 7% increase in patent applications for immuno-oncology compared to the previous quarter, indicating a dynamic transformation in the oncology landscape. Interestingly, along with patent filing, we also saw companies actively acquiring patents in the domain. Thus confirming that it’s not just the number of patent filings […]
First to get ANDA approval for a generic drug
With companies filing for ANDAs, the global prescribed generics sales are expected to reach nearly 100 billion U.S. dollars by 2026. One example of this is Rexulti – a prescription medicine used along with antidepressant medicines to treat major depressive disorder (MDD) in adults. Zydus Pharmaceuticals stood out by being among the first applicants to submit […]
Impact of the Unitary Patent & Unified Patent Court? Key Steps to Consider
European Patent (EP) has been a common patent valid across 39 contracting member states (27 EU countries and 12 other European countries). However, the downside of it has been that the patentee must validate the EP patent within different contracting countries separately after its grant. In addition, once the EP patent is granted, the post-grant proceedings/procedures […]
Patent Databases: 18 Best Free and Paid Patent Search Platforms
The choice of patent databases highly depends on the motive beneath it, or in other words, the type of patent search involved. For instance, for a prior art search that is for current litigation, you would want to choose a patent database that covers the patent documents of most of the patent offices. Exhaustiveness is […]
What’s next for Humira Biosimilars as the drug’s exclusivity ends?
Are you familiar with Humira? The first fully lab-made immune protein approved by the US Food and Drug Administration (FDA) for various treatments. In case you aren’t, Humira is a blockbuster anti-inflammatory drug made by AbbVie, which is losing its market exclusivity in 2023. The drug treats conditions like rheumatoid arthritis, psoriasis, Crohn’s disease, and […]
Get Access to your Patent Litigation Landscape – It Can Protect Your Business
As the chip shortage lingers upon the world, TeleGrey, one of our clients from the telecommunications industry, approached us with a plan to get into chip development to become self-reliant. Just like other tech giants, they saw a whitespace in the semiconductor industry and aimed to venture into the domain. However, there were a lot […]
5 Patents in Self-driving that could be threat to every automobile company
As innovation in self-driving technology is picking up the pace, acquiring the right patents can be crucial for IP managers to ensure their company stays ahead of the competition. But it isn’t as easy, and you already know that. Analyzing multiple patents and figuring out the best of the lot can get cumbersome. To make […]
How Nokia & OnePlus could have made a stronger impact in the global market?
In 2019, OnePlus Technology faced a legal battle when EVS codec tech LLC & Saint Lawrence Communications- two U.S. NPEs sued this Chinese mobile giant for infringing on the patents related to wideband signals. While OnePlus was on the route to extracting the benefits of global expansion, it became a prime target for litigation in […]
Learn from Apple and Google to go beyond the survival during recession!
Imagine you’re Mike, the IP Counsel of a leading technology manufacturing company. With the economy slowly slipping into a recession, you must ensure that your company doesn’t sink. This means you must protect your company’s existing IP and identify new opportunities for growth and innovation. Since you realize how important it is to invest in […]